News & Blog
Sort by :
Tumor Tip of the Week-Lymphovascular Invasion and Neoadjuvant Therapy
Scenario: 2022 Question: How would you code Lymphovascular invasion? Answer: 9 Rationale: STORE 2022 f. For cases treated with neoadjuvant therapy, refer to table below
-
Omega Healthcare
-
22 August
Tumor Tip of the Week-Kidney Single Tumor with 2 or variants of that NOS
Scenario: 2022 diagnosis is a single tumor with renal cell carcinoma (RCC) 8312, papillary renal cell carcinoma 8260, and mucinous tubular and spindle cell carcinoma
-
Omega Healthcare
-
16 August
Tumor Tip of the Week-Pericolonic/Pericolorectal tissue Invaded-Reg or Local
#1 Scenario: 2022 pT3 pN0 cM0 Stage IIA Transverse Colon with Extension through the wall into pericolic tissue, 16 nodes (-), no mets on CT.
-
Omega Healthcare
-
01 August
Omega Healthcare Named “Star Performer” in RCM Operations PEAK Matrix® Assessment 2022
Omega Healthcare Named “Star Performer” in Revenue Cycle Management (RCM) Operations PEAK Matrix® Assessment 2022 Marks the fifth year that Omega has been ranked as
-
Omega Healthcare
-
18 July
Tumor Tip of the Week-Multiple Papillary and Multiple Follicular Ca of the Thyroid-Single or Multiple Primary?
Question: If you had multiple papillary tumors such as a micropapillary 8260/3 and a papillary tall cell 8344/3 would we apply rule M6 (single primary)
-
Omega Healthcare
-
18 July
Tumor Tip of the week: Cirrhosis-Fibrosis Score
Scenario: 2022 patient presents to facility and biopsy of liver shows hepatocellular carcinoma scans reveal changes of hepatic cirrhosis, no further workup done, patient expires.
-
Omega Healthcare
-
05 July